VTGN - VistaGen Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Total Revenue
0
0
0
1,250
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
18,669
17,099
7,763
5,204
3,932
Selling General and Administrative
7,902
7,458
6,437
6,295
13,919
Total Operating Expenses
26,571
24,557
14,200
11,499
17,850
Operating Income or Loss
-26,571
-24,556
-14,199
-10,249
-17,850
Interest Expense
-
8
9
5
777
Total Other Income/Expenses Net
-
-23
-135
5
-28,591
Income Before Tax
-26,582
-24,587
-14,343
-10,253
-47,218
Income Tax Expense
3
3
2
2
2
Income from Continuing Operations
-26,585
-24,590
-14,346
-10,255
-47,220
Net Income
-26,585
-24,590
-14,346
-10,255
-47,220
Net Income available to common shareholders
-27,754
-25,729
-15,575
-11,624
-51,419
Reported EPS
Basic
-
-0.90
-1.12
-1.54
-29.08
Diluted
-
-0.90
-1.12
-1.54
-29.08
Weighted average shares outstanding
Basic
-
28,562
13,890
7,532
1,768
Diluted
-
28,562
13,890
7,532
1,768
EBITDA
-
-24,465
-14,119
-10,193
-46,388